Application of Group Interpersonal Psychotherapy (IPT-G) to Family Members Caring for Patients With Schizophrenia

NCT05870384 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2024-08-07

No results posted yet for this study

Summary

The goal of this re-measured quasi-experimental study is to evaluate the effect of Group Interpersonal Psychotherapy (IPT-G) intervention given to caregiver family members of people with schizophrenia on caregiver burden, perception of social support and stigma, adherence to treatment in people with schizophrenia they care for, and emotional expression in both caregivers and people with schizophrenia they care for. The main hypotheses it aims to test are:

1. IPT-G intervention will reduce the caregiver burden of caregivers of individuals with schizophrenia.
2. IPT-G intervention will increase the perceived social support levels of caregivers of individuals with schizophrenia.
3. IPT-G intervention will reduce the level of stigma of caregivers of individuals with schizophrenia.
4. IPT-G intervention will reduce the level of emotional expression of caregivers of individuals with schizophrenia.
5. IPT-G intervention applied to caregivers will increase the level of adherence to treatment of individuals with schizophrenia they care for.
6. IPT-G intervention applied to caregivers will reduce the emotional expression levels of individuals with schizophrenia they care for.

Conditions

  • Interpersonal Psychotherapy
  • Family Caregivers

Interventions

BEHAVIORAL

Group Interpersonal Psychotherapy

Ten sessions of IPT-G, which focuses on the common problem area of patient relatives, will be applied.

Sponsors & Collaborators

  • Abant Izzet Baysal University

    lead OTHER

Principal Investigators

  • Melisa Bulut · Bolu Abant İzzet Baysal University

  • Nazmiye Yıldırım · Bolu Abant İzzet Baysal University

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-07-31
Primary Completion
2024-10-31
Completion
2025-04-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05870384 on ClinicalTrials.gov